Aisling Capital Management LP Buys Zosano Pharma Corp

Author's Avatar
Feb 06, 2020
Article's Main Image
Investment company Aisling Capital Management LP (Current Portfolio) buys Zosano Pharma Corp during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Aisling Capital Management LP. As of 2019Q4, Aisling Capital Management LP owns 12 stocks with a total value of $255 million. These are the details of the buys and sells.
  • Added Positions: ZSAN,

For the details of Aisling Capital Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/aisling+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Aisling Capital Management LP
  1. BridgeBio Pharma Inc (BBIO) - 3,835,722 shares, 52.72% of the total portfolio.
  2. Eidos Therapeutics Inc (EIDX) - 1,123,630 shares, 25.29% of the total portfolio.
  3. Avrobio Inc (AVRO) - 893,079 shares, 7.05% of the total portfolio.
  4. Aeglea BioTherapeutics Inc (AGLE) - 1,291,151 shares, 3.87% of the total portfolio.
  5. Marker Therapeutics Inc (GX1N) - 2,000,000 shares, 2.26% of the total portfolio.
Added: Zosano Pharma Corp (ZSAN)

Aisling Capital Management LP added to a holding in Zosano Pharma Corp by 34.00%. The purchase prices were between $1.37 and $2.4, with an estimated average price of $1.76. The stock is now traded at around $1.12. The impact to a portfolio due to this purchase was 0.41%. The holding were 2,718,226 shares as of .



Here is the complete portfolio of Aisling Capital Management LP. Also check out:

1. Aisling Capital Management LP's Undervalued Stocks
2. Aisling Capital Management LP's Top Growth Companies, and
3. Aisling Capital Management LP's High Yield stocks
4. Stocks that Aisling Capital Management LP keeps buying